Evidence map›Paper›PMID 33133046›Full record

ReviewFrontiers in microbiology2020

Viral Hepatitis E and Chronicity: A Growing Public Health Concern.

Vikram Thakur, Radha Kanta Ratho, Swatantra Kumar, Shailendra K Saxena, Ishani Bora, Pryanka Thakur

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Research Progress on Hepatitis E Virus Culture.Pathogens (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. HEV Infection in Beta-Thalassemia Patients.Pathogens (Basel, Switzerland) · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vikram ThakurDepartment of Virology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Radha Kanta RathoDepartment of Virology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Swatantra KumarCentre for Advanced Research, Faculty of Medicine, King George's Medical University, Lucknow, India.
Shailendra K SaxenaCentre for Advanced Research, Faculty of Medicine, King George's Medical University, Lucknow, India.
Ishani BoraDepartment of Virology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Pryanka ThakurDepartment of Virology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis E viral infection recently emerges as a global health concern. Over the last decade, the understanding of hepatitis E virus (HEV) had changed with the discovery of new genotypes like genotype-7 and genotype-8 with associated host and mode of infection. Diversification in the mode of hepatitis E infection transmission through blood transfusion, and organ transplants in contrast to classical feco-oral and zoonotic mode is the recent medical concern. The wide spectrum of infection ranging from self-limiting to acute liver failure is now overpowered by HEV genotype-specific chronic infection especially in transplant patients. This concern is further escalated by the extra-hepatic manifestations of HEV targeting the central nervous system (CNS), kidney, heart, and pancreas. However, with the development of advanced efficient cell culture systems and animal models simulating the infection, much clarity toward understanding the pathogenetic mechanism of HEV has been developed. Also this facilitates the development of vaccines research or therapeutics. In this review, we highlight all the novel findings in every aspect of HEV with special emphasis on recently emerging chronic mode of infection with specific diagnosis and treatment regime with an optimistic hope to help virologists and/or liver specialists working in the field of viral hepatitis.

Indexed as

chronicitygenotypeshepatitis E virusimmunocompromisedorgan transplantsribavirin

Identifiers

PMID33133046
PMCPMC7550462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.